36 studies found for:    " June 08, 2013":" July 08, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" June 08, 2013":" July 08, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Safety and Immunogenicity of Recombinant HIV Vaccines for HIV/AIDS
Condition: Acquired Immunodeficiency Syndrome
Interventions: Biological: Saline Solution;   Biological: D-GPEi;   Biological: M-GPE
2 Recruiting Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions
Conditions: Human Immunodeficiency Virus;   Hepatitis B, Chronic;   Hepatitis C, Chronic
Intervention: Drug: antiretroviral drugs
3 Completed Use of Male Circumcision Device in All Four Childhood Groups in the African Population
Condition: Human Immunodeficiency Virus
Intervention: Device: Male circumcision using the Shang Ring device
4 Recruiting Viral Biofilms: Hijacking T Cell Extracellular Matrix to Regulate HIV-1 Spread?
Condition: HIV Infection
Intervention: Other: Blood sample
5 Recruiting EFV Pharmacokinetics & Pharmacogenomics in Older HIV-infected Patients
Condition: HIV Infection
Intervention: Drug: Efavirenz
6 Not yet recruiting A Prospective, Open-label Trial of Two Abacavir/Lamivudine Based Regimen (ABC/3TC + Darunavir/Ritonavir or ABC/3TC + Raltegravir) in Late Presenter naïve Patients (With CD4 Count <200 Cells/µL - Advanced HIV Disease)
Condition: HIV Infection
Interventions: Drug: abacavir/lamivudine + raltegravir;   Drug: abacavir/lamivudine + darunavir/ritonavir
7 Active, not recruiting A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of Maraviroc
Conditions: HIV Infection;   HIV-1 Infection;   Mycobacterium Avium Complex (MAC)
Interventions: Drug: Rifabutin;   Drug: Maraviroc
8 Recruiting Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone
Conditions: Opiate Dependence;   Human Immunodeficiency Virus
Interventions: Drug: injectable naltrexone;   Drug: placebo comparator
9 Recruiting Epicardial Adipose Tissue And Coronary Risk In HIV-Infected Patients
Condition: Hiv Infection
Intervention: Biological: blood sampling,
10 Active, not recruiting Primary HIV Prevention in Pregnant and Lactating Ugandan Women
Condition: Primary Prevention of HIV Acquisition
Intervention: Behavioral: Extended repeat HIV testing and enhanced counseling
11 Recruiting Prevalence of Histoplasmosis in HIV + Patients With a Rapid Diagnostic Test in West Indies
Condition: HIV
Intervention:
12 Not yet recruiting Determining the Effect of Abacavir on Platelet Activation
Conditions: HIV;   Cardiovascular Disease
Intervention: Drug: Abacavir
13 Not yet recruiting Switch to Maraviroc + Raltegravir
Condition: HIV
Intervention: Drug: Switch to Maraviroc + Raltegravir
14 Recruiting Randomized Trial of an HIV Navigation Program for Early Palliative Care
Conditions: HIV;   Chronic Disease
Intervention: Other: Patient Navigation
15 Recruiting Maternal HIV Disclosure to School Children: RCT of Family-based Intervention
Conditions: HIV;   Disclosure
Intervention: Behavioral: Amagugu Counseling Intervention
16 Completed Targeted Screening of At-Risk Adults for Acute HIV-1 Infection
Condition: HIV
Intervention: Behavioral: intense follow up
17 Recruiting Multicomponent Intervention to Reduce Sexual Risk and Substance Use
Conditions: HIV;   Sexually Transmitted Infections;   Substance Use
Intervention: Behavioral: MI + CBST Intervention
18 Recruiting Situkulwane Lesiphephile-Safe Generations
Condition: HIV/AIDS
Intervention: Other: Option B+
19 Enrolling by invitation A Phase I Study to Evaluate the Safety and Immunogenicity of Heterologous Boost Immunizations With MVA-CMDR
Condition: HIV Prevention
Interventions: Biological: MVA-CMDR;   Biological: Placebo
20 Recruiting Tauroursodeoxycholic Acid for Protease-inhibitor Associated Insulin Resistance
Conditions: HIV Related Insulin Resistance;   Protease Inhibitor Related Insulin Resistance;   Endoplasmic Reticulum Stress
Intervention: Drug: Tauroursodeoxycholic acid

   Previous Page Studies Shown (1-20) Next Page (21-36) Show next page of results    Last Page
Indicates status has not been verified in more than two years